Viracta Therapeutics Inc. (VIRX)
Market Closed
2 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 01
0
0%
After Hours
$
+0 +11.4519% 0. 01
388.7K Market Cap
- P/E Ratio
- Div Yield
379,813 Volume
- Eps
$ 0.01
Previous Close Want to track VIRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Sunesis (VIRX) Is a Great 'Buy the Bottom' Stock Now
Sunesis (VIRX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks | 1 year ago
Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today?
Viracta Therapeutics (NASDAQ: VIRX ) stock is heading higher on Wednesday after the clinical-stage precision oncology company released its Q2 earnings report. The first bit of news boosting VIRX stock higher is its diluted earnings per share of -25 cents.
Investorplace | 1 year ago
